These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 17210912)

  • 1. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
    Prince ME; Sivanandan R; Kaczorowski A; Wolf GT; Kaplan MJ; Dalerba P; Weissman IL; Clarke MF; Ailles LE
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):973-8. PubMed ID: 17210912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells in head and neck squamous cell carcinoma.
    Ailles L; Prince M
    Methods Mol Biol; 2009; 568():175-93. PubMed ID: 19582427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
    Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
    Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9.
    Sterz CM; Kulle C; Dakic B; Makarova G; Böttcher MC; Bette M; Werner JA; Mandic R
    Oral Oncol; 2010 Feb; 46(2):116-22. PubMed ID: 20036607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.
    Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM
    Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.
    Krishnamurthy S; Dong Z; Vodopyanov D; Imai A; Helman JI; Prince ME; Wicha MS; Nör JE
    Cancer Res; 2010 Dec; 70(23):9969-78. PubMed ID: 21098716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells.
    Lo WL; Chien Y; Chiou GY; Tseng LM; Hsu HS; Chang YL; Lu KH; Chien CS; Wang ML; Chen YW; Huang PI; Hu FW; Yu CC; Chu PY; Chiou SH
    Biomaterials; 2012 May; 33(14):3693-709. PubMed ID: 22361100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.
    Sun S; Wang Z
    Int J Cancer; 2011 Nov; 129(10):2337-48. PubMed ID: 21225626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
    Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
    Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
    Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
    Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
    Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
    Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma.
    Khammanivong A; Gopalakrishnan R; Dickerson EB
    Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
    Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
    PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
    Kidwai F; Costea DE; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.
    Chiu CC; Lee LY; Li YC; Chen YJ; Lu YC; Li YL; Wang HM; Chang JT; Cheng AJ
    Cancer Gene Ther; 2013 Nov; 20(11):606-15. PubMed ID: 24201869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.